Sudha Chakrapni, Ph.D., Case Western Reserve University (IMAGE)
Caption
Drug improvement has been stalled by a lack of models showing exactly how drugs like setrons attach to their target protein in the body. Without a precise model, drug developers have been unable to understand exactly which elements of setron-receptor interactions are most important, and how to enhance them. Chakrapani hopes to change that with her research.
Credit
Case Western Reserve University School of Medicine
Usage Restrictions
None
License
Licensed content